Searched for
GLYCEMIC CONTROL EXERCISES
Dr Reddy’s launches generic Semaglutide injection, popular weight-loss drug, in CanadaDr Reddy's Laboratories has launched its generic Semaglutide injection in Canada. This marks a significant step for the company in providin...
10 squats vs 30-minute walk?: According to longevity expert Bryan Johnson, this post-meal habit effectively controls blood sugar levelsA new idea suggests frequent squats can manage blood sugar better than a long walk. Biohacker Bryan Johnson proposes 10 squats every 45 min...
Forget intense workouts: Scientists say this simple two-exercise combo may be the smartest and most affordable way to beat diabetesA new pilot study from Assam, India, published in Cureus, finds that combining yoga and walking may be one of the most effective low cost w...
Think it’s too late to lose weight? Doctors say one overlooked habit can restart your metabolism and transform your healthLosing weight becomes more challenging with age due to slower metabolism and reduced muscle mass, yet experts say it’s achievable with the ...
CMC Vellore trained doctor shares 5 ways to manage type 2 diabetes beyond medicinesDr. Sudhir Kumar shares five strategies to manage type 2 diabetes. He emphasizes food choices like legumes and whole grains. Regular exerci...
Sanofi introduces diabetes drug Soliqua in IndiaSanofi India has launched its diabetes drug Soliqua in India, a once-daily injectable combination drug containing insulin and GLP-1 recepto...
How to control your sugar cravingsOne of the most effective hacks for controlling sugar cravings is to control your blood sugar levels. The key to this hack is to eat foods ...
Sanofi launches new long-acting insulin drug in IndiaSoliqua is indicated as treatment to improve glycemic control as an adjunct to diet and exercise, in adults with obesity and type 2 diabete...
Having a handful of almonds before meals can improve blood sugar levels in prediabetics, says studyA few almonds 30 mins before breakfast, lunch, and dinner throughout the study duration.
Lupin gets USFDA nod for generic diabetes drugThe company has received tentative approval for the product in multiple strengths from the United States Food and Drug Administration (USFD...
Zydus Cadila gets tentative nod from USFDA to market diabetes drugThe company said the newly approved medication will be manufactured at the group's formulation manufacturing facility at the SEZ, Ahmedabad.
Zydus Healthcare launches generic anti-diabetic Dapagliflozin tablets in IndiaThe once-daily tablets are indicated as an adjunct to diet and exercise, and aim to improve glycemic control in adults with Type 2 diabetes...
Macleods Pharma USA Inc recalls 31,968 bottles of diabetes drug in USMacleods Pharma USA Inc has declared Pioglitazone Hydrochloride tablets used for treatment of diabetes in America to be superpotent which w...
AstraZeneca Pharma India gets DCGI nod to market diabetes drugThe product is indicated as an adjunct therapy to diet and exercise to improve glycemic control in adults with type 2 diabetes, AstraZeneca...
Do you work night shifts? Diabetes could be harder to controlThe study shows that night shift work is associated with an increased risk for the development of diabetes.
Attention, ladies! Ways to combat Poly Cystic Ovarian DiseasePCOD has become common a cause of female infertility. From a proper diet, exercise & stress management, it needs comprehensive care.
Marksans Pharma gets USFDA nod for diabetes treatment tabletsThe product is generic version of Bristol Meyers Squibb's Glucophage XR extended release tablets in the same strengths, it added.
Lupin launches generic diabetes drug in the USLupin has launched 10 products in the US this fiscal year and has received approvals for 21 from the FDA. The drug maker has 35 FTF product...
Lupin gets USFDA approval for diabetes management drug"Lupin's Pioglitazone tablets is to improve glycemic control in adults with type 2 diabetes mellitus in multiple clinical settings," the co...
Aurobindo Pharma gets USFDA nod for Repaglinide tabletsThe approval is for multiple strengths of the drug in 0.5mg, 1mg and 2mg. The product is ready for launch, the company said in a statement.